Loading clinical trials...
Loading clinical trials...
Effects of Cholecalciferol on Osteoprotegerin Levels and Other Clinical Outcomes in Chronic Kidney Disease Patients on Peritoneal Dialysis: a Randomized Controlled Trial
Conditions
Interventions
Cholecalciferol
Placebo
Locations
1
Mexico
National Medical Science and Nutrition Institute Salvador Zubiran MEXICO
Mexico City, Mexico City, Mexico
Start Date
October 1, 2015
Primary Completion Date
October 1, 2016
Completion Date
June 1, 2017
Last Updated
March 24, 2017
NCT01524276
NCT07262333
NCT03188796
NCT05694689
NCT02769975
NCT06450925
Lead Sponsor
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions